Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ultragenyx
Fierce Biotech
FDA plans real-time release of drug rejection letters
Alongside the new policy, the FDA released 89 new complete response letters, adding to the more than 200 that were previously made public in July.
Darren Incorvaia
Sep 4, 2025 1:45pm
FDA snubs Ultragenyx gene therapy over manufacturing issues
Jul 14, 2025 10:16am
Novartis, Viatris now face litigation over use of HeLa cells
Aug 6, 2024 8:06am
Henrietta Lacks' estate sues Ultragenyx over gene therapy vector
Aug 11, 2023 9:35am
The most influential people in biopharma in 2023
May 9, 2023 3:00am
FDA says children age 5-11 now eligible for Regeneron's Evkeeza
Mar 22, 2023 10:39am
